We are live on ! Find out more
AVA

Atlas Venture Advisors Portfolio holdings

AUM $122M
1-Year Est. Return 26.28%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
-26.28%
3 Year Est. Return
-22.79%
5 Year Est. Return
-46.44%
10 Year Est. Return
AUM
$290M
AUM Growth
+$12.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Communication Services 70.46%
2 Consumer Discretionary 25.76%
3 Healthcare 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IAS
1
DELISTED
Integral Ad Science
IAS
$200M 68.9%
22,722,771
DKNG icon
2
DraftKings
DKNG
$11.4B
$74.7M 25.76%
6,555,608
VRDN icon
3
Viridian Therapeutics
VRDN
$2.13B
$6.12M 2.11%
209,505
FSTX
4
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$3.63M 1.25%
574,996
ROKU icon
5
Roku
ROKU
$21.1B
$2.35M 0.81%
57,707
SNAP icon
6
Snap
SNAP
$7.32B
$2.2M 0.76%
245,559
LRMR icon
7
Larimar Therapeutics
LRMR
$416M
$1.21M 0.42%
292,184

Similar funds

Atlas Venture Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Atlas Venture Advisors held 7 positions worth $290M, up 4.4% from $278M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 0%. Atlas Venture Advisors opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Communication Services at 70% of assets, up from 61% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Atlas Venture Advisors's ten largest holdings make up 100% of its $290M portfolio in Q4 2022.
  • Atlas Venture Advisors opened 0 new positions and closed 0 in Q4 2022.
  • Atlas Venture Advisors's portfolio value rose 4.4% quarter-over-quarter to $290M.

Based on Atlas Venture Advisors's 13F filing for Q4 2022, filed 31 Jan 2023.